Keyphrases
Hepatitis B Virus
100%
Immune Suppression
100%
Co-infected Patients
100%
Tenofovir
100%
Confidence Interval
42%
Odds Ratio
42%
Antigen Loss
42%
Hepatitis B Surface Antigen (HBsAg)
42%
CD4 Count
42%
Liver
28%
Hepatocellular Carcinoma
28%
Highly Active Antiretroviral Therapy (HAART)
28%
Hepatitis B Virus DNA
28%
Liver-related Mortality
28%
Clinical Outcomes
14%
Mortality Rate
14%
HIV Patients
14%
Predictive Factors
14%
Logistic Regression
14%
High Mortality
14%
Median Time
14%
Hepatitis C Virus
14%
Liver Disease
14%
Log-rank Test
14%
Liver Failure
14%
Virus Interference
14%
Patients Included
14%
Overall Mortality
14%
Cirrhosis Diagnosis
14%
Liver Complications
14%
Antigen Clearance
14%
Liver Decompensation
14%
Hepatitis C Coinfection
14%
Virological Outcome
14%
HBV e Antigen
14%
Hepatitis B Virus e Antigen
14%
Hepatitis B Virus HBV
14%
Medicine and Dentistry
Immunosuppressive Treatment
100%
Human immunodeficiency virus
100%
Hepatitis B Virus
100%
Tenofovir
100%
Odds Ratio
23%
Membrane Antigen
15%
Hepatitis C Virus
15%
Hepatocellular Carcinoma
15%
Highly Active Antiretroviral Therapy
15%
Virus DNA
15%
Liver Failure
7%
Mortality Rate
7%
Logistic Regression Analysis
7%
Decompensated Liver Cirrhosis
7%
Liver Disease
7%
Log Rank Test
7%
Liver Cirrhosis
7%
Hepatitis B(e) Antigen
7%
Mixed Infection
7%
Outcome Assessment
7%
Immunology and Microbiology
Human immunodeficiency virus
100%
Hepatitis B Virus
100%
Tenofovir
100%
CD4 Lymphocyte Count
23%
DNA Virus
15%
Membrane Antigen
15%
Hepatitis C Virus
15%
Mortality Rate
7%
Coinfection
7%
Hepatitis B(e) Antigen
7%